Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life

被引:2
|
作者
Wang, Jia-Jie [1 ]
Zheng, Zhichao [1 ]
Zhang, Ying [1 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Cardiol, 106 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China
来源
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 09期
关键词
CAC; MASLD; obesity; overweight; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; RISK DEVELOPMENT; UNITED-STATES; WEIGHT-LOSS; OBESITY; PREVALENCE; NUTRITION; ADOLESCENTS; MANAGEMENT;
D O I
10.1111/dom.15733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimThe association of overweight/obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) in young adulthood with subclinical atherosclerosis [coronary artery calcification (CAC) and abdominal aortic calcification (AAC)] by middle age is unknown.MethodIn total, 2274 participants aged 28-39 years from the coronary artery risk development in young adults study at year 10 (1995-1996) who were re-examined 15 years later were included. CAC and AAC were measured at year 25 using computed tomography. We examined the utility of three young adult phenotypes (lean group; overweight/obese group; overweight/obese MASLD group) at year 10 in predicting CAC or AAC by middle age. Modified Poisson regression was used to estimate the association between groups and CAC, and AAC. Independent determinates of CAC and AAC were determined with linear regression models.ResultsCompared with individuals categorized as lean in young adulthood, the relative risk for CAC by middle age was 1.09 (95% confidence interval: 0.93-1.28) for those with overweight/obesity and 1.32 (95% confidence interval: 1.08-1.61) for those with overweight/obesity-related MASLD. For AAC, no difference was observed between these three groups. Group, systolic blood pressure and group x systolic blood pressure interaction were all the independent determinates for CAC.ConclusionIn this study, young adults with overweight/obesity-related MASLD have a higher risk of developing CAC by middle age. These abnormalities are only partially explained by traditional cardiovascular risk factors, and overweight/obesity-related MASLD has an independent impact on CAC. Our study provides evidence for identifying young adults at higher risk of developing subclinical atherosclerosis.
引用
收藏
页码:3860 / 3867
页数:8
相关论文
共 50 条
  • [31] From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
    Lonardo, Amedeo
    Weiskirchen, Ralf
    METABOLITES, 2024, 14 (08)
  • [32] Life's essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
    Zhang, Yingying
    Wang, Pingping
    Tu, Fan
    Kang, Hao
    Fu, Chengfeng
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [33] Association of liver fibrosis progression with non-liver-related mortality in metabolic dysfunction-associated steatotic liver disease
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Koshiyama, Yuichi
    Akita, Tomoyuki
    Kodama, Yuzo
    Tanaka, Junko
    HEPATOLOGY RESEARCH, 2025,
  • [34] Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
    Zong, Guannan
    Mao, Wangjia
    Wen, Ming
    Cheng, Xiaoyun
    Liu, Guanghui
    ANNALS OF HEPATOLOGY, 2025, 30 (02)
  • [35] Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
    Chen, Mei-jing
    Chen, Ying
    Lin, Jin-qing
    Hu, Rong
    Liu, Dun
    Chen, Jing-yi
    Li, Ka
    Jiang, Xiao-ying
    FRONTIERS IN NUTRITION, 2025, 11
  • [36] The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
    Perumpail, Brandon J.
    Manikat, Richie
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    Kim, Donghee
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (01): : 110 - 118
  • [37] Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease with renal insufficiency in overweight/obese adults
    Shi, Ameng
    Deng, Jiang
    Ma, Juan
    Yang, Longbao
    Tantai, Xinxing
    Wang, Qian
    Chang, Danyan
    Wang, Jinhai
    Guo, Xiaoyan
    Lu, Xiaolan
    Shi, Haitao
    OBESITY FACTS, 2023, 16 (06) : 548 - 558
  • [38] Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage
    Clayton-Chubb, Daniel
    Kemp, William W.
    Majeed, Ammar
    Lubel, John S.
    Woods, Robyn L.
    Tran, Cammie
    Ryan, Joanne
    Hodge, Alexander
    Schneider, Hans G.
    Mcneil, John J.
    Roberts, Stuart K.
    LIVER INTERNATIONAL, 2024, 44 (01) : 39 - 51
  • [39] Body Composition and Pediatric Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease Using Magnetic Resonance Imaging and Elastography
    Dong, A. M.
    Adamos, T. R.
    Kafali, S.
    Shih, S.
    Delgado-Esbenshade, T.
    Mohpatra, S.
    Li, J.
    Ghahremani, S.
    Wu, H. H.
    Calkins, K. L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 395 - 397
  • [40] Gender and age differences in the impact of overweight on obesity-related quality of life among Korean adults
    Song, H. R.
    Park, H. S.
    Yun, K. E.
    Cho, S. H.
    Choi, E. Y.
    Lee, S. Y.
    Kim, J. H.
    Sung, H. N.
    Kim, J. H.
    Choi, S. I.
    Yoon, Y. S.
    Lee, E. S.
    Han, J. H.
    Shin, C. I.
    Chang, H. M.
    Bae, S. C.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2010, 4 (01) : E15 - E23